Literature DB >> 24756510

Acetazolamide for pseudotumor cerebri: evidence from the NORDIC trial.

Jonathan C Horton1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24756510      PMCID： PMC6145171          DOI： 10.1001/jama.2014.3325

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  Effects of acetazolamide on CSF pressure and electrolytes in hydrocephalus.

Authors:  L BIRZIS; C H CARTER; T H MAREN
Journal:  Neurology       Date:  1958-07       Impact factor: 9.910

2.  Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.

Authors:  Michael Wall; Michael P McDermott; Karl D Kieburtz; James J Corbett; Steven E Feldon; Deborah I Friedman; David M Katz; John L Keltner; Eleanor B Schron; Mark J Kupersmith
Journal:  JAMA       Date:  2014 Apr 23-30       Impact factor: 56.272

3.  Idiopathic intracranial hypertension: relationship to depression, anxiety, and quality of life.

Authors:  J J Kleinschmidt; K B Digre; R Hanover
Journal:  Neurology       Date:  2000-01-25       Impact factor: 9.910

4.  Gastric surgery for pseudotumor cerebri associated with severe obesity.

Authors:  H J Sugerman; W L Felton; A Sismanis; J M Kellum; E J DeMaria; E L Sugerman
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969

5.  Pediatric idiopathic intracranial hypertension and extreme childhood obesity.

Authors:  Sonu M Brara; Corinna Koebnick; Amy H Porter; Annette Langer-Gould
Journal:  J Pediatr       Date:  2012-05-26       Impact factor: 4.406

Review 6.  Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs.

Authors:  D Friesner; R Rosenman; B M Lobb; E Tanne
Journal:  Obes Rev       Date:  2010-08-26       Impact factor: 9.213

Review 7.  Interventions for idiopathic intracranial hypertension.

Authors:  C Lueck; G McIlwaine
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

Review 8.  Surgical and endovascular interventions in idiopathic intracranial hypertension.

Authors:  Arielle Spitze; Amina Malik; Andrew G Lee
Journal:  Curr Opin Neurol       Date:  2014-02       Impact factor: 5.710

9.  The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri)

Authors:  L N Johnson; G B Krohel; R W Madsen; G A March
Journal:  Ophthalmology       Date:  1998-12       Impact factor: 12.079

Review 10.  Idiopathic intracranial hypertension.

Authors:  Devin K Binder; Jonathan C Horton; Michael T Lawton; Michael W McDermott
Journal:  Neurosurgery       Date:  2004-03       Impact factor: 4.654
  10 in total
  2 in total

Review 1.  Neuro-ophthalmology and neuro-otology update.

Authors:  Daniel R Gold; David S Zee
Journal:  J Neurol       Date:  2015-06-30       Impact factor: 4.849

Review 2.  Noninvasive assessment of cerebrospinal fluid pressure.

Authors:  Beau B Bruce
Journal:  J Neuroophthalmol       Date:  2014-09       Impact factor: 3.042
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.